Blackstone Group Inc.

SEC CIK: 0001393818
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SABS holding history

SAB Biotherapeutics, Inc. in every 13F filed by Blackstone Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SABS overview All 13F holders of SABS Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of SABS by Blackstone Group Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−860,170−100.0%	Sold out	Holders
Q1 2026	860,170	$3.29M	<0.1%	−1,283,415−59.9%	Reduced	Holders
Q4 2025	2,143,585	$8.02M	<0.1%	+2,143,585	New	Holders